HolderBook

NURIX THERAPEUTICS INC (NRIX)

Institutional ownership reported to the SEC as of Q3 2026, across 25 quarters.

4
Reporting holders
$128.4K
Reported value
0.0%
Calls
0.0%
Puts
-211
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
Farther Finance Advisors, LLC$95.2K4,0140.00%6q+755.9%+$84.1K
GAMMA Investing LLC$30.1K1,2700.00%12q+95.4%+$14.7K
MassMutual Private Wealth & Trust, FSB$1.7K720.00%4qHELD
Versant Capital Management, Inc$1.4K610.00%2qHELD

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-09-2313GPerceptive Advisors LLCwith 2 co-filers5.3%
2026-08-1413GT. Rowe Price Associates, Inc.5.3%
2026-08-1413G/AVestal Point Capital, LPwith 1 co-filers7.8%
2026-08-1413GRubric Capital Management LPwith 1 co-filers7.0%
2026-08-1413G/ARedmile Group, LLCwith 2 co-filers8.1%
2026-08-1413G/ADeep Track Capital, LPwith 2 co-filers7.5%
2026-07-3113GVanguard Capital Management5.0%

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-06-25Ring ChristineChief Legal OfficerSold28,935$580.5K
2026-08-03Ring ChristineChief Legal OfficerSold16,589$382.4K
2026-07-02Ring ChristineChief Legal OfficerSold11,008$259.4K
2026-05-05van Houte HansChief Financial OfficerSold14,055$233.3K ×2
2026-09-02Ring ChristineChief Legal OfficerSold5,787$149.1K ×2
2026-05-04Ring ChristineChief Legal OfficerSold8,148$138.2K
2026-06-02Ring ChristineChief Legal OfficerSold8,148$135.3K
2026-10-02Ring ChristineChief Legal OfficerSold5,786$134.1K
2026-08-04van Houte HansChief Financial OfficerSold4,761$116.0K ×2
2026-08-05Hansen GwennChief Scientific OfficerSold4,356$108.9K
2026-06-25Hansen GwennChief Scientific OfficerSold5,394$107.9K
2026-08-04Hansen GwennChief Scientific OfficerSold4,111$100.1K ×2

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20264$128.4K5,4170200.0%
Q2 2026215$3.0B124,567,4474968610.3%
Q1 2026195$1.8B117,536,3103767410.2%
Q4 2025182$2.2B113,925,7053391290.3%
Q3 2025172$792.3M85,618,9023449560.2%
Q2 2025165$1.0B88,547,6802565440.2%
Q1 2025170$1.0B84,700,0812865490.1%
Q4 2024176$1.5B81,104,6032764430.5%
Q3 2024172$1.5B67,949,9462859540.2%
Q2 2024173$1.4B65,045,0865061440.2%
Q1 2024140$797.1M54,182,1462939440.1%
Q4 2023131$509.0M49,262,2711943350.1%
Q3 2023130$353.0M44,887,4651439460.1%
Q2 2023125$438.5M43,679,9891643390.6%
Q1 2023123$383.1M42,968,7721743350.6%
Q4 2022118$470.6M42,704,4301843290.4%
Q3 2022116$562.7M43,051,8802047220.3%
Q2 2022104$574.6M45,302,5431145270.4%
Q1 2022115$567.7M40,379,8941742310.4%
Q4 2021123$1.2B40,469,0062042310.0%
Q3 2021113$1.2B39,480,8732429320.0%
Q2 2021103$1.0B39,520,8441950150.0%
Q1 202199$1.3B41,346,1253739100.0%
Q4 202068$1.1B33,138,6541127100.0%
Q3 202066$1.1B31,854,91565000.0%